GH - Exact Sciences: Still No Reason To Own
2024-06-11 13:45:23 ET
Summary
- We are revisiting oncology testing company Exact Sciences Corporation today for the first time in nearly a year and a half.
- The shares have been cut by more than half since last summer, despite revenue growth in the low teens and strong support from the analyst firm community.
- Is it time to buy the dip? An updated analysis around Exact Sciences follows in the paragraphs below.
Today, we put Exact Sciences Corporation ( EXAS ) in the spotlight. The last time we took a look at this oncology diagnostic concern was in February 2023. We concluded that article with the conclusion, the shares were more than fully priced at the around $65 level after a significant rally....
Exact Sciences: Still No Reason To Own